Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2003-04-25
2010-10-05
Saoud, Christine J (Department: 1647)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
C424S133100, C424S135100, C424S139100, C424S141100, C424S143100, C530S387100, C530S387300, C530S387900, C530S388100, C530S388220
Reexamination Certificate
active
07807153
ABSTRACT:
Novel polypeptides, designated Apo-2, which are capable of modulating apoptosis are provided. Compositions including Apo-2 chimeras, nucleic acid encoding Apo-2, and antibodies to Apo-2 are also provided.
REFERENCES:
patent: 3691016 (1972-09-01), Patel
patent: 3969287 (1976-07-01), Jaworek et al.
patent: 4179337 (1979-12-01), Davis et al.
patent: 4195128 (1980-03-01), Hildebrand et al.
patent: 4229537 (1980-10-01), Hodgins et al.
patent: 4247642 (1981-01-01), Hirohara et al.
patent: 4301144 (1981-11-01), Iwashita et al.
patent: 4330440 (1982-05-01), Ayers et al.
patent: 4342566 (1982-08-01), Theofilopoulos et al.
patent: 4399216 (1983-08-01), Axel et al.
patent: 4419446 (1983-12-01), Howley et al.
patent: 4496689 (1985-01-01), Mitra
patent: 4601978 (1986-07-01), Karin
patent: 4640835 (1987-02-01), Shimizu et al.
patent: 4670417 (1987-06-01), Iwasaki et al.
patent: 4676980 (1987-06-01), Segal et al.
patent: 4736866 (1988-04-01), Leder et al.
patent: 4791192 (1988-12-01), Nakagawa et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4855235 (1989-08-01), Takahashi et al.
patent: 4870009 (1989-09-01), Evans et al.
patent: 4965199 (1990-10-01), Capon et al.
patent: 5010182 (1991-04-01), Brake et al.
patent: 5153118 (1992-10-01), Wright, Jr. et al.
patent: 5158885 (1992-10-01), Bradstock et al.
patent: 5194596 (1993-03-01), Tischer et al.
patent: 5350836 (1994-09-01), Kopchick
patent: 5364934 (1994-11-01), Drayna et al.
patent: 5580756 (1996-12-01), Linsley
patent: 5756667 (1998-05-01), Lewis
patent: 5756677 (1998-05-01), Lewis et al.
patent: 5763223 (1998-06-01), Wiley et al.
patent: 5910574 (1999-06-01), Presta et al.
patent: 6046048 (2000-04-01), Ashkenazi et al.
patent: 6072047 (2000-06-01), Rauch et al.
patent: 6252050 (2001-06-01), Ashkenazi
patent: 6313269 (2001-11-01), Deen et al.
patent: 6342369 (2002-01-01), Ashkenazi
patent: 6417328 (2002-07-01), Alnemri
patent: 6455040 (2002-09-01), Wei et al.
patent: 6455262 (2002-09-01), Cox et al.
patent: 6635743 (2003-10-01), Ebner et al.
patent: 6689744 (2004-02-01), Gao et al.
patent: 6743625 (2004-06-01), Ni et al.
patent: 6872568 (2005-03-01), Ni et al.
patent: 7314619 (2008-01-01), Adams
patent: 7528239 (2009-05-01), Rauch et al.
patent: 2002/0004227 (2002-01-01), Ashkenazi
patent: 2002/0048566 (2002-04-01), El-Deiry et al.
patent: 2002/0048785 (2002-04-01), Holtzman
patent: 2002/0072091 (2002-06-01), Ni et al.
patent: 2002/0098550 (2002-07-01), Ni et al.
patent: 2002/0115154 (2002-08-01), Alnemri
patent: 2002/0150985 (2002-10-01), Adams
patent: 2002/0160446 (2002-10-01), Holtzman
patent: 2002/0161195 (2002-10-01), Alnemri
patent: 2002/0161196 (2002-10-01), Alnemri
patent: 2003/0004313 (2003-01-01), Ashkenazi
patent: 2003/0017161 (2003-01-01), Ashkenazi
patent: 2003/0133932 (2003-07-01), Zhou et al.
patent: 2003/0148455 (2003-08-01), Ashkenazi
patent: 2003/0180296 (2003-09-01), Salcedo et al.
patent: 2004/0009552 (2004-01-01), Adams
patent: 2004/0136951 (2004-07-01), Ni et al.
patent: 2005/0233958 (2005-10-01), Ni
patent: 2005/0282230 (2005-12-01), Ashkenazi
patent: 2006/0035334 (2006-02-01), Adams
patent: 2006/0073570 (2006-04-01), Adams
patent: 2006/0084147 (2006-04-01), Adams
patent: 2006/0115484 (2006-06-01), Adams
patent: 2006/0251647 (2006-11-01), Adams
patent: 2007/0015247 (2007-01-01), Ashkenazi
patent: 266710 (1989-04-01), None
patent: 036776 (1981-09-01), None
patent: 073657 (1983-03-01), None
patent: 117058 (1984-08-01), None
patent: 117060 (1984-08-01), None
patent: 125023 (1984-11-01), None
patent: 173494 (1986-03-01), None
patent: 278776 (1988-08-01), None
patent: 307247 (1989-03-01), None
patent: 321196 (1989-06-01), None
patent: 362179 (1990-04-01), None
patent: 417563 (1991-03-01), None
patent: 510691 (1992-10-01), None
patent: 870827 (1998-10-01), None
patent: 2211504 (1989-07-01), None
patent: WO 87/05330 (1987-09-01), None
patent: WO 89/02922 (1989-04-01), None
patent: WO 89/05859 (1989-06-01), None
patent: WO 90/13646 (1990-11-01), None
patent: WO 91/00358 (1991-01-01), None
patent: WO 91/00360 (1991-01-01), None
patent: WO 91/08291 (1991-06-01), None
patent: WO 92/01047 (1992-01-01), None
patent: WO 92/01810 (1992-02-01), None
patent: WO 92/20373 (1992-11-01), None
patent: WO 92/20791 (1992-11-01), None
patent: WO 93/00109 (1993-01-01), None
patent: WO 93/06213 (1993-04-01), None
patent: WO 93/08829 (1993-05-01), None
patent: WO 93/11236 (1993-06-01), None
patent: WO 93/19172 (1993-09-01), None
patent: WO 94/04679 (1994-03-01), None
patent: WO 94/04690 (1994-03-01), None
patent: WO 94/29348 (1994-12-01), None
patent: WO 95/01438 (1995-01-01), None
patent: WO 95/10540 (1995-04-01), None
patent: WO 95/11301 (1995-04-01), None
patent: WO 95/15388 (1995-06-01), None
patent: WO 95/31544 (1995-11-01), None
patent: WO 97/01633 (1997-01-01), None
patent: WO 97/25428 (1997-07-01), None
patent: WO 98/35986 (1998-08-01), None
patent: WO 98/41629 (1998-09-01), None
patent: WO 98/46643 (1998-10-01), None
patent: WO 98/51793 (1998-11-01), None
patent: WO 98/58062 (1998-12-01), None
patent: WO 99/02653 (1999-01-01), None
patent: WO 99/09165 (1999-02-01), None
patent: WO 99/11791 (1999-03-01), None
patent: WO 99/12963 (1999-03-01), None
patent: WO 99/64461 (1999-12-01), None
patent: WO 00/66156 (2000-11-01), None
patent: WO 00/77191 (2000-12-01), None
patent: WO 02/053727 (2002-07-01), None
patent: WO 02/094880 (2002-11-01), None
patent: WO 03/037913 (2003-05-01), None
patent: WO 03/038043 (2003-05-01), None
U.S. Appl. No. 08/799,861, filed Feb. 13, 1997.
U.S. Appl. No. 08/815,255, filed Mar. 12, 1997.
U.S. Appl. No. 08/820,364, filed Mar. 12, 1997, Gearing.
U.S. Appl. No. 08/829,536, filed Mar. 28, 1997.
U.S. Appl. No. 08/843,651, filed Apr. 16, 1997, Holtzman.
U.S. Appl. No. 08/843,652, filed Apr. 16, 1997, Holtzman.
U.S. Appl. No. 08/853,684, filed May 9, 1997.
U.S. Appl. No. 08/869,852, filed Jun. 4, 1997.
U.S. Appl. No. 08/883,036, filed Jun. 26, 1997.
U.S. Appl. No. 08/916,625, filed Aug. 22, 1997.
U.S. Appl. No. 09/042,583, filed Mar. 17, 1998.
U.S. Appl. No. 09/565,009, filed May 4, 2000.
U.S. Appl. No. 09/712,726, filed Nov. 14, 2000, Gearing.
U.S. Appl. No. 60/040,846, filed Mar. 17, 1997.
U.S. Appl. No. 60/041,230, filed Mar. 14, 1997.
U.S. Appl. No. 60/054,021, filed Jul. 29, 1997.
U.S. Appl. No. 60/132,498, filed May, 4, 1999.
U.S. Appl. No. 60/133,238, filed May 7, 1999.
U.S. Appl. No. 60/148,939, filed Aug. 13, 1999.
Adams et al., “Molecular cloning of mouse immunoglobulin heavy chain messenger ribonucleic acids coding for μ, α, γ1, γ2a, and γ3 chains”Biochemistry19:2711-2719 (1980).
Amakawa et al., “The Hodgkin Disease Antigen CD30 is Crucial for Antigen-Induced Death of Developing T Cells”Symposium on Programmed Cell Death(Abstract No. 10), Cold Spring Harbor Laboratory (1995).
Aplin and Wriston, “Preparation, Properties, and Applications of Carbohydrate Conjugates of Proteins and Lipids”CRC Crit. Rev. Biochem. 10(4):259-306 (1981).
Ashkenazi and Chamow, “Immunoadhesins: An Alternative to Human Monoclonal Antibodies”Methods: A Companion to Methods in Enzymology8:104-115 (1995).
Ashkenazi et al., “Induction of Apoptosis by APO-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family”European Cytokine Network7:159 (1996).
Ashkenazi et al., “Protection Against Endotoxic Shock by a Tumor Necrosis Factor Receptor Immunoadhesin”Proc. Natl. Acad. Sci. 88:10535-10539 (1991).
Autologous Bone Marrow Transplantation: Proceedings of the Third International Symposium, Dicke et al., University of Texas M.D. Anderson Hospital (1987).
Baldwin, A., “The NF-κB and IκB Proteins: New Discoveries and Insights”Ann. Rev. Immunol. 14:649-683 (1996).
Banerji et al., “A Lymphocyte-specific Cellular Enhancer Is Located Downstream of the Joining Region in Immunoglobulin Heavy Chain Genes”Cell33:729-740 (Jul. 1983).
Banner et al., “Crystal Structure of the Soluble Human 55 kd TNF Receptor-Human TNFβ Complex: Implications for TNF Receptor Activation&#x
Adams Camellia W.
Ashkenazi Avi J.
Chuntharapai Anan
Kim Kyung Jin
Genentech Inc.
Lockard Jon M
Saoud Christine J
Sidley Austin LLP
LandOfFree
Apo-2 receptor agonist antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Apo-2 receptor agonist antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apo-2 receptor agonist antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4223105